The Development Status Of Pharmaceutical Companies In India

Paharmaceutical companies in India has grown rapidly in the past 10 years. Although the market size is much smaller than some mainstream pharmaceutical markets in the world, some leading pharmaceutical companies in India have an increasing influence on the global pharmaceutical market. At this stage, India is the largest generic drug producer in the world, accounting for about 20% of the total global generic drug exports. At the same time, India is also one of the fastest growing regions in the global pharmaceutical industry. Now, some of the leading companies in the Indian pharmaceutical industry are leading the Indian pharmaceutical market and continue to increase their presence in the global market, here are some pharmaceutical companies in India.

Sun Pharmaceutical Industries Ltd. is the number one pharmaceutical company in India established in 1983. At present, the company has operations in more than 150 countries around the world, including the United States, Africa and Canada, and is known as the largest pharmaceutical company in India. Indian Sun Pharma Ltd is a leader in every therapeutic area it is involved in and has been voted as one of the best pharmaceutical companies by important clients.

Lupin Limited is the second-ranked well-known pharmaceutical company in India, headquartered in Mumbai, engaged in the production of a series of high-quality generic drugs or branded preparation drugs and API business, and is one of the three largest pharmaceutical companies in India. Launched in 1968, Lupin has gained international recognition for the huge success of the tuberculosis drug. At present, in the global pharmaceutical market, Lupin has a large market share in the fields of cardiovascular, diabetes, asthma, pediatrics, central nervous system, anti-infective and non-steroidal anti-inflammatory drugs.

Dr. Reddy's Laboratories is the third largest Indian multinational pharmaceutical company headquartered in Hyderabad, Telangana. Dr Reddy's laboratory manufactures and distributes a range of pharmaceutical products in India and overseas. The company manufactures more than 190 drugs, 60 active pharmaceutical ingredient drugs, diagnostic kits, critical care and biotechnology products.

CIPLA is the second largest pharmaceutical company in India, with strong capital and scientific research strength. Cipla is mainly engaged in anti-AIDS drugs, anti-infective drugs, anti-cancer drugs and respiratory drugs. Its products are mainly chemical drugs. In recent years, it has also actively participated in the field of biomedicine. Biosimilars for Immune Diseases-An analogue of the antibody fusion protein drug Enbrel.

Aurobindo is committed to producing what many people around the world need drug. The company is headquartered in Hyderabad, India, and more than 50% of its products are exported to more than 100 countries, Arabindo manufactures hundreds of different active medicines that other manufacturers need to produce medicines.In addition, it produces its own antibiotics, anti-filtering pathogens, anti-depressants, anti-fungals and cardiovascular drugs. Sales of its products have grown by more than 315% in the past few years, making the company one of the top five manufacturers of pharmaceuticals sold in India and one of the top five manufacturers of synthetic penicillin in the world. In 2004 Forbes magazine named Arabindo as one of the 100 fastest growing companies in Asia.

Cadila Healthcare is one of largest privatized pharmaceutical companies in India headquartered in Ahmedabad, Gujarat. For the past 60 years, the company has been developing and manufacturing pharmaceutical products in India, and the products have been sold in 85 countries around the world. Cadila's main products include cardiovascular drugs, gastroenterology drugs, analgesics, blood tonics, anti-infective and antibiotic drugs, respiratory disease drugs, hypoglycemic drugs and immune drugs.

Development proposals

First of all, companies need to increase investment to improve the research and development level of generic drugs, pay close attention to the development trend of international generic drugs, and keep up with the pace of generic drug development. Second, accelerate the technological integration of biotechnology and the pharmaceutical industry, so that biotechnology can play a greater role in drug production. Finally, deepen the reform of the domestic drug market, such as the reform of the drug price formation mechanism and the reform of the drug circulation system, to improve the marketization level of the drug market.

Summary

With the full implementation of the strategy of building a national innovation system and improving the capability of independent innovation, it is the general trend to speed up the construction of innovative pharmaceutical enterprises. The pharmaceutical market is a big space with rapid changes and unlimited development. Pharmaceutical companies in various countries must continue to study the market, enhance flexibility and adaptability, find out their positioning, formulate strategies that suit their own development and unswervingly implement them.